Table 3.

Clinical situations which would prevent participants to start testosterone treatment

Clinical situation	Endocrinologists would restrain from starting testosterone therapy (%)	Urologists would restrain from starting testosterone therapy (%)
The patient had an acute myocardial infarction 5 months ago that required coronary stenting. He now feels well without symptoms of angina or cardiac failure	35	13
The patient had radical prostatectomy 3 years ago for localized prostate cancer (T2cN0M0). The Gleason score at diagnostic was 7 (grade group 2). Since surgery the PSA level is undetectable.	58.3	27.5
The patient has benign prostate hypertrophy, confirmed by biopsy. His PSA level is 4.2. The disease severity as assessed by IPSS is 10 and the disease-specific quality of life score is 2	25	7.5
The patient has moderate obstructive sleep apnea, BMI of 35.5 kg/m2 and does not tolerate CPAP oxygen therapy	58.3	37.5
The patient is smoking and has a hematocrit of >52%	100	85

BMI = body mass index; CPAP = continuous positive airway pressure; IPSS = International Prostate Symptom Score; PSA = prostate-specific antigen.